Brenus Pharma reports favorable tolerability and clinical signals in early preliminary results of first-in-human study for STC-1010 in unresectable metastatic stage MSS CRC patients
BIG BPI – Brenus Pharma took part in the roundtable: “The French biotech ecosystem conquering European markets“
